Drug-Eluting Stents Perform Well In An Emergency, NEJM Data Shows
This article was originally published in The Gray Sheet
Executive Summary
Drug-eluting stents reduce the rates of two-year mortality, heart attack recurrence and repeat revascularization compared with bare-metal stents in acute myocardial infarction patients, according to the results of a large observational study reported Sept. 25
You may also be interested in...
Boston Scientific Hopes New Data Will Expand Boundaries Of DES Population
Boston Scientific expects the new data from two trials released at the Transcatheter Cardiovascular Therapeutics Scientific Symposium in Washington, D.C., last week will encourage physicians to reconsider drug-eluting stents for a broader range of patients
Boston Scientific Hopes New Data Will Expand Boundaries Of DES Population
Boston Scientific expects the new data from two trials released at the Transcatheter Cardiovascular Therapeutics Scientific Symposium in Washington, D.C., last week will encourage physicians to reconsider drug-eluting stents for a broader range of patients
In An Emergency, Value Of Drug-Eluting Stents Still Questionable, Docs Say
More data is needed before drug-eluting stents should be considered for routine use as part of emergency treatment for a heart attack, according to an editorial in the Sept. 14 New England Journal of Medicine